Tumor Ablation Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (Cryoablation, Radiofrequency (RF) Ablation, Microwave Ablation and Others), Application (Lung Cancer, Liver Cancer, Kidney Cancer, Bone Metastasis and Others), Mode of Treatment (Percutaneous Ablation, Surgical Ablation, Laparoscopic Ablation, Others), and Geography

Report Code: TIPHE100001314 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW
:
Tumor ablation is a minimally invasive procedure for treating liver, kidney, bone, and lung cancers. Thermal energy is utilized to heat or cool tissue to cytotoxic levels during tumor ablation. Many patients with minor hepatocellular carcinomas or benign tumors in the liver are considering ablation as a first-line treatment. Tumor ablation is a minimally invasive surgical procedure for the treatment of solid tumours. Without the need for surgery, special probes are utilised to "burn" or "freeze" tumours. The needle probe is guided and positioned into the tumour using computed tomography (CT), ultrasound (US), or magnetic resonance imaging (MRI).

MARKET SCOPE

The "Tumor Ablation Market to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Tumor Ablation Market with detailed market segmentation by of Type, Application, Source and End Users. The Tumor Ablation Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Tumor Ablation Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  n the basis of Technology, the market is segmented into Cryoablation, Radiofrequency (RF) Ablation, Microwave Ablation and Others.
  •  n the basis of Application, the market is segmented into Lung Cancer, Liver Cancer, Kidney Cancer, Bone Metastasis and Others.
  •  n the basis of Treatment, the market is segmented into Percutaneous Ablation, Surgical Ablation, Laparoscopic Ablation, Others.

MARKET DYNAMICS
Drivers

  •  Rising geriatric population, increasing prevalence of cancer would be an important factor to drive the market for pressure devices.
  •  In addition, Various technological advancements in the healthcare business in Asia Pacific and Europe are projected to provide chances for market to offer growth opportunities for tumor ablation market.

Restraints

    In the projection period, a lack of awareness about the indicators of Cancer and a lack of financial aid for the poor could hinder the market.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Tumor Ablation Marketbased on various segments. It also provides market size and forecast estimates from year 2017 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Tumor Ablation Marketby each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Tumor Ablation Marketfrom both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the Tumor Ablation Market in these regions.

IMPACT OF COVID-19 ON CELL SEPARATION SYSTEMS MARKET:
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. The global impacts of the COVID-19 are already starting to be felt, and will significantly affect the Tumor Ablation Market in 2020.Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the Tumor Ablation Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Tumor Ablation Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Tumor Ablation Market in the global market. Below mentioned is the list of few companies engaged in the Cell Separation Systems Market.

The report also includes the profiles of key players in Tumor Ablation Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
  •  HEALTHTRONICS, INC.
  •  BOSTON SCIENTIFIC CORPORATION
  •  MISONIX, INC.
  •  MERMAID MEDICAL A/S
  •  NEUWAVE MEDICAL, INC.
  •  MEDTRONIC, PLC
  •  ANGIODYNAMICS, INC.
  •  GALIL MEDICAL, INC.
  •  EDAP TMS S.A.
  •  SONACARE MEDICAL LLC

    The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
  • TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Tumor Ablation Market - By Technology
    1.3.2 Tumor Ablation Market - By Application
    1.3.3 Tumor Ablation Market - By Treatment
    1.3.4 Tumor Ablation Market - By Region
    1.3.4.1 By Country
    2. KEY TAKEAWAYS
    3. RESEARCH METHODOLOGY
    4. TUMOR ABLATION MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PEST ANALYSIS
    4.2.1 North America - Pest Analysis
    4.2.2 Europe - Pest Analysis
    4.2.3 Asia-Pacific - Pest Analysis
    4.2.4 Middle East and Africa - Pest Analysis
    4.2.5 South and Central America - Pest Analysis
    4.3. EXPERT OPINIONS
    5. TUMOR ABLATION MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
    6. TUMOR ABLATION MARKET - GLOBAL MARKET ANALYSIS
    6.1. TUMOR ABLATION - GLOBAL MARKET OVERVIEW
    6.2. TUMOR ABLATION - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING
    7. TUMOR ABLATION MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
    7.1. OVERVIEW
    7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
    7.3. CRYOABLATION
    7.3.1. Overview
    7.3.2. Cryoablation Market Forecast and Analysis
    7.4. RADIOFREQUENCY (RF) ABLATION
    7.4.1. Overview
    7.4.2. Radiofrequency (RF) Ablation Market Forecast and Analysis
    7.5. MICROWAVE ABLATION
    7.5.1. Overview
    7.5.2. Microwave Ablation Market Forecast and Analysis
    7.6. STEREOTACTIC BODY RADIOTHERAPY (SBRT)
    7.6.1. Overview
    7.6.2. Stereotactic Body Radiotherapy (SBRT) Market Forecast and Analysis
    7.7. OTHERS
    7.7.1. Overview
    7.7.2. Others Market Forecast and Analysis
    8. TUMOR ABLATION MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
    8.1. OVERVIEW
    8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
    8.3. LUNG CANCER
    8.3.1. Overview
    8.3.2. Lung Cancer Market Forecast and Analysis
    8.4. LIVER CANCER
    8.4.1. Overview
    8.4.2. Liver Cancer Market Forecast and Analysis
    8.5. KIDNEY CANCER
    8.5.1. Overview
    8.5.2. Kidney Cancer Market Forecast and Analysis
    8.6. BONE METASTASIS
    8.6.1. Overview
    8.6.2. Bone Metastasis Market Forecast and Analysis
    8.7. OTHERS
    8.7.1. Overview
    8.7.2. Others Market Forecast and Analysis
    9. TUMOR ABLATION MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT
    9.1. OVERVIEW
    9.2. TREATMENT MARKET FORECASTS AND ANALYSIS
    9.3. PERCUTANEOUS ABLATION
    9.3.1. Overview
    9.3.2. Percutaneous Ablation Market Forecast and Analysis
    9.4. SURGICAL ABLATION
    9.4.1. Overview
    9.4.2. Surgical Ablation Market Forecast and Analysis
    9.5. LAPAROSCOPIC ABLATION
    9.5.1. Overview
    9.5.2. Laparoscopic Ablation Market Forecast and Analysis
    9.6. OTHERS
    9.6.1. Overview
    9.6.2. Others Market Forecast and Analysis
    10. TUMOR ABLATION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    10.1. NORTH AMERICA
    10.1.1 North America Tumor Ablation Market Overview
    10.1.2 North America Tumor Ablation Market Forecasts and Analysis
    10.1.3 North America Tumor Ablation Market Forecasts and Analysis - By Technology
    10.1.4 North America Tumor Ablation Market Forecasts and Analysis - By Application
    10.1.5 North America Tumor Ablation Market Forecasts and Analysis - By Treatment
    10.1.6 North America Tumor Ablation Market Forecasts and Analysis - By Countries
    10.1.6.1 United States Tumor Ablation Market
    10.1.6.1.1 United States Tumor Ablation Market by Technology
    10.1.6.1.2 United States Tumor Ablation Market by Application
    10.1.6.1.3 United States Tumor Ablation Market by Treatment
    10.1.6.2 Canada Tumor Ablation Market
    10.1.6.2.1 Canada Tumor Ablation Market by Technology
    10.1.6.2.2 Canada Tumor Ablation Market by Application
    10.1.6.2.3 Canada Tumor Ablation Market by Treatment
    10.1.6.3 Mexico Tumor Ablation Market
    10.1.6.3.1 Mexico Tumor Ablation Market by Technology
    10.1.6.3.2 Mexico Tumor Ablation Market by Application
    10.1.6.3.3 Mexico Tumor Ablation Market by Treatment
    10.2. EUROPE
    10.2.1 Europe Tumor Ablation Market Overview
    10.2.2 Europe Tumor Ablation Market Forecasts and Analysis
    10.2.3 Europe Tumor Ablation Market Forecasts and Analysis - By Technology
    10.2.4 Europe Tumor Ablation Market Forecasts and Analysis - By Application
    10.2.5 Europe Tumor Ablation Market Forecasts and Analysis - By Treatment
    10.2.6 Europe Tumor Ablation Market Forecasts and Analysis - By Countries
    10.2.6.1 Germany Tumor Ablation Market
    10.2.6.1.1 Germany Tumor Ablation Market by Technology
    10.2.6.1.2 Germany Tumor Ablation Market by Application
    10.2.6.1.3 Germany Tumor Ablation Market by Treatment
    10.2.6.2 France Tumor Ablation Market
    10.2.6.2.1 France Tumor Ablation Market by Technology
    10.2.6.2.2 France Tumor Ablation Market by Application
    10.2.6.2.3 France Tumor Ablation Market by Treatment
    10.2.6.3 Italy Tumor Ablation Market
    10.2.6.3.1 Italy Tumor Ablation Market by Technology
    10.2.6.3.2 Italy Tumor Ablation Market by Application
    10.2.6.3.3 Italy Tumor Ablation Market by Treatment
    10.2.6.4 Spain Tumor Ablation Market
    10.2.6.4.1 Spain Tumor Ablation Market by Technology
    10.2.6.4.2 Spain Tumor Ablation Market by Application
    10.2.6.4.3 Spain Tumor Ablation Market by Treatment
    10.2.6.5 United Kingdom Tumor Ablation Market
    10.2.6.5.1 United Kingdom Tumor Ablation Market by Technology
    10.2.6.5.2 United Kingdom Tumor Ablation Market by Application
    10.2.6.5.3 United Kingdom Tumor Ablation Market by Treatment
    10.2.6.6 Rest of Europe Tumor Ablation Market
    10.2.6.6.1 Rest of Europe Tumor Ablation Market by Technology
    10.2.6.6.2 Rest of Europe Tumor Ablation Market by Application
    10.2.6.6.3 Rest of Europe Tumor Ablation Market by Treatment
    10.3. ASIA-PACIFIC
    10.3.1 Asia-Pacific Tumor Ablation Market Overview
    10.3.2 Asia-Pacific Tumor Ablation Market Forecasts and Analysis
    10.3.3 Asia-Pacific Tumor Ablation Market Forecasts and Analysis - By Technology
    10.3.4 Asia-Pacific Tumor Ablation Market Forecasts and Analysis - By Application
    10.3.5 Asia-Pacific Tumor Ablation Market Forecasts and Analysis - By Treatment
    10.3.6 Asia-Pacific Tumor Ablation Market Forecasts and Analysis - By Countries
    10.3.6.1 Australia Tumor Ablation Market
    10.3.6.1.1 Australia Tumor Ablation Market by Technology
    10.3.6.1.2 Australia Tumor Ablation Market by Application
    10.3.6.1.3 Australia Tumor Ablation Market by Treatment
    10.3.6.2 China Tumor Ablation Market
    10.3.6.2.1 China Tumor Ablation Market by Technology
    10.3.6.2.2 China Tumor Ablation Market by Application
    10.3.6.2.3 China Tumor Ablation Market by Treatment
    10.3.6.3 India Tumor Ablation Market
    10.3.6.3.1 India Tumor Ablation Market by Technology
    10.3.6.3.2 India Tumor Ablation Market by Application
    10.3.6.3.3 India Tumor Ablation Market by Treatment
    10.3.6.4 Japan Tumor Ablation Market
    10.3.6.4.1 Japan Tumor Ablation Market by Technology
    10.3.6.4.2 Japan Tumor Ablation Market by Application
    10.3.6.4.3 Japan Tumor Ablation Market by Treatment
    10.3.6.5 South Korea Tumor Ablation Market
    10.3.6.5.1 South Korea Tumor Ablation Market by Technology
    10.3.6.5.2 South Korea Tumor Ablation Market by Application
    10.3.6.5.3 South Korea Tumor Ablation Market by Treatment
    10.3.6.6 Rest of Asia-Pacific Tumor Ablation Market
    10.3.6.6.1 Rest of Asia-Pacific Tumor Ablation Market by Technology
    10.3.6.6.2 Rest of Asia-Pacific Tumor Ablation Market by Application
    10.3.6.6.3 Rest of Asia-Pacific Tumor Ablation Market by Treatment
    10.4. MIDDLE EAST AND AFRICA
    10.4.1 Middle East and Africa Tumor Ablation Market Overview
    10.4.2 Middle East and Africa Tumor Ablation Market Forecasts and Analysis
    10.4.3 Middle East and Africa Tumor Ablation Market Forecasts and Analysis - By Technology
    10.4.4 Middle East and Africa Tumor Ablation Market Forecasts and Analysis - By Application
    10.4.5 Middle East and Africa Tumor Ablation Market Forecasts and Analysis - By Treatment
    10.4.6 Middle East and Africa Tumor Ablation Market Forecasts and Analysis - By Countries
    10.4.6.1 South Africa Tumor Ablation Market
    10.4.6.1.1 South Africa Tumor Ablation Market by Technology
    10.4.6.1.2 South Africa Tumor Ablation Market by Application
    10.4.6.1.3 South Africa Tumor Ablation Market by Treatment
    10.4.6.2 Saudi Arabia Tumor Ablation Market
    10.4.6.2.1 Saudi Arabia Tumor Ablation Market by Technology
    10.4.6.2.2 Saudi Arabia Tumor Ablation Market by Application
    10.4.6.2.3 Saudi Arabia Tumor Ablation Market by Treatment
    10.4.6.3 U.A.E Tumor Ablation Market
    10.4.6.3.1 U.A.E Tumor Ablation Market by Technology
    10.4.6.3.2 U.A.E Tumor Ablation Market by Application
    10.4.6.3.3 U.A.E Tumor Ablation Market by Treatment
    10.4.6.4 Turkey Tumor Ablation Market
    10.4.6.4.1 Turkey Tumor Ablation Market by Technology
    10.4.6.4.2 Turkey Tumor Ablation Market by Application
    10.4.6.4.3 Turkey Tumor Ablation Market by Treatment
    10.4.6.5 Rest of Middle East and Africa Tumor Ablation Market
    10.4.6.5.1 Rest of Middle East and Africa Tumor Ablation Market by Technology
    10.4.6.5.2 Rest of Middle East and Africa Tumor Ablation Market by Application
    10.4.6.5.3 Rest of Middle East and Africa Tumor Ablation Market by Treatment
    10.5. SOUTH AND CENTRAL AMERICA
    10.5.1 South and Central America Tumor Ablation Market Overview
    10.5.2 South and Central America Tumor Ablation Market Forecasts and Analysis
    10.5.3 South and Central America Tumor Ablation Market Forecasts and Analysis - By Technology
    10.5.4 South and Central America Tumor Ablation Market Forecasts and Analysis - By Application
    10.5.5 South and Central America Tumor Ablation Market Forecasts and Analysis - By Treatment
    10.5.6 South and Central America Tumor Ablation Market Forecasts and Analysis - By Countries
    10.5.6.1 Brazil Tumor Ablation Market
    10.5.6.1.1 Brazil Tumor Ablation Market by Technology
    10.5.6.1.2 Brazil Tumor Ablation Market by Application
    10.5.6.1.3 Brazil Tumor Ablation Market by Treatment
    10.5.6.2 Argentina Tumor Ablation Market
    10.5.6.2.1 Argentina Tumor Ablation Market by Technology
    10.5.6.2.2 Argentina Tumor Ablation Market by Application
    10.5.6.2.3 Argentina Tumor Ablation Market by Treatment
    10.5.6.3 Rest of South and Central America Tumor Ablation Market
    10.5.6.3.1 Rest of South and Central America Tumor Ablation Market by Technology
    10.5.6.3.2 Rest of South and Central America Tumor Ablation Market by Application
    10.5.6.3.3 Rest of South and Central America Tumor Ablation Market by Treatment
    11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL TUMOR ABLATION MARKET
    11.1 North America
    11.2 Europe
    11.3 Asia-Pacific
    11.4 Middle East and Africa
    11.5 South and Central America
    12. INDUSTRY LANDSCAPE
    12.1. MERGERS AND ACQUISITIONS
    12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    12.3. NEW PRODUCT LAUNCHES
    12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
    13. TUMOR ABLATION MARKET, KEY COMPANY PROFILES
    13.1. HEALTHTRONICS, INC.
    13.1.1. Key Facts
    13.1.2. Business Description
    13.1.3. Products and Services
    13.1.4. Financial Overview
    13.1.5. SWOT Analysis
    13.1.6. Key Developments
    13.2. BOSTON SCIENTIFIC CORPORATION
    13.2.1. Key Facts
    13.2.2. Business Description
    13.2.3. Products and Services
    13.2.4. Financial Overview
    13.2.5. SWOT Analysis
    13.2.6. Key Developments
    13.3. MISONIX, INC.
    13.3.1. Key Facts
    13.3.2. Business Description
    13.3.3. Products and Services
    13.3.4. Financial Overview
    13.3.5. SWOT Analysis
    13.3.6. Key Developments
    13.4. MERMAID MEDICAL A/S
    13.4.1. Key Facts
    13.4.2. Business Description
    13.4.3. Products and Services
    13.4.4. Financial Overview
    13.4.5. SWOT Analysis
    13.4.6. Key Developments
    13.5. NEUWAVE MEDICAL, INC.
    13.5.1. Key Facts
    13.5.2. Business Description
    13.5.3. Products and Services
    13.5.4. Financial Overview
    13.5.5. SWOT Analysis
    13.5.6. Key Developments
    13.6. MEDTRONIC, PLC
    13.6.1. Key Facts
    13.6.2. Business Description
    13.6.3. Products and Services
    13.6.4. Financial Overview
    13.6.5. SWOT Analysis
    13.6.6. Key Developments
    13.7. ANGIODYNAMICS, INC.
    13.7.1. Key Facts
    13.7.2. Business Description
    13.7.3. Products and Services
    13.7.4. Financial Overview
    13.7.5. SWOT Analysis
    13.7.6. Key Developments
    13.8. GALIL MEDICAL, INC.
    13.8.1. Key Facts
    13.8.2. Business Description
    13.8.3. Products and Services
    13.8.4. Financial Overview
    13.8.5. SWOT Analysis
    13.8.6. Key Developments
    13.9. EDAP TMS S.A.
    13.9.1. Key Facts
    13.9.2. Business Description
    13.9.3. Products and Services
    13.9.4. Financial Overview
    13.9.5. SWOT Analysis
    13.9.6. Key Developments
    13.10. SONACARE MEDICAL LLC
    13.10.1. Key Facts
    13.10.2. Business Description
    13.10.3. Products and Services
    13.10.4. Financial Overview
    13.10.5. SWOT Analysis
    13.10.6. Key Developments
    14. APPENDIX
    14.1. ABOUT THE INSIGHT PARTNERS
    14.2. GLOSSARY OF TERMS


    The List of Companies

    1. HEALTHTRONICS, INC.
    2. BOSTON SCIENTIFIC CORPORATION
    3. MISONIX, INC.
    4. MERMAID MEDICAL A/S
    5. NEUWAVE MEDICAL, INC.
    6. MEDTRONIC, PLC
    7. ANGIODYNAMICS, INC.
    8. GALIL MEDICAL, INC.
    9. EDAP TMS S.A.
    10. SONACARE MEDICAL LLC
    11. STARmed
    12. RF Medical
    13. Olympus
    14. Johnson and Johnson
    15. Surgnova Healthcare Technologies
    16. ECHO Microwave
    TIPHE100001314
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Pricing

    Free

    20%

    customization on Pre-Booking